Isoxazolines and isoxazoles as factor Xa inhibitors.

被引：0
|
作者：
Pruitt, JR [1 ]
Pinto, DJ [1 ]
Quan, ML [1 ]
Estrella, MJ [1 ]
Bostrom, LL [1 ]
Knabb, RM [1 ]
Wong, PC [1 ]
Wexler, RR [1 ]
机构：
[1] Dupont Merck Pharmaceut Co, Wilmington, DE 19880 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 216卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
077-MEDI
引用
收藏
页码：U224 / U224
页数：1
相关论文
共 50 条
  • [1] Isoxazolines and isoxazoles as Factor Xa inhibitors
    Pruitt, JR
    Pinto, DJ
    Estrella, MJ
    Bostrom, LL
    Knabb, RM
    Wong, PC
    Wright, MR
    Wexler, RR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (08) : 685 - 689
  • [2] Benzoxazole thrombin and Factor Xa inhibitors.
    Deng, JZ
    Burgey, CS
    Rabbat, PMA
    Lewis, SD
    Lucas, BJ
    Krueger, JA
    White, RB
    Wong, B
    Lyle, EA
    McMasters, DR
    Lynch, JJ
    Yan, YW
    Chen, ZG
    Kuo, L
    Vacca, JP
    Lyle, TA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U14 - U15
  • [3] Benzoxazole thrombin and factor Xa inhibitors.
    Deng, JZW
    Burgey, CS
    Rabbat, PMA
    Lewis, SD
    Lucas, BJ
    Krueger, JA
    White, RB
    Wong, B
    Lyle, EA
    McMasters, DR
    Lynch, JJ
    Yan, YW
    Chen, ZG
    Kuo, L
    Vacca, JP
    Lyle, TA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U23 - U23
  • [4] Structural studies of factor Xa inhibitors.
    Whitlow, M
    Seto, M
    Koovakkat, S
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U899 - U899
  • [5] Nonbenzamidine tetrazole derivatives as factor Xa inhibitors.
    Quan, ML
    Ellis, CD
    He, MY
    Liauw, AY
    Lam, PW
    Alexander, RS
    Knabb, RM
    Wright, MR
    Wong, PC
    Wexler, RR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U9 - U9
  • [6] Therapeutic Potential of Oral Factor Xa Inhibitors.
    Hylek, Elaine M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26): : 2559 - 2561
  • [7] Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors.
    Quan, ML
    Ellis, CD
    He, MY
    Liauw, AY
    Lam, PY
    Knabb, RM
    Rossi, KA
    Wright, MR
    Wong, PC
    Wexler, RR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U9 - U9
  • [8] Development of potent and selective factor Xa inhibitors.
    Rai, R
    Kolesnikov, A
    Young, WB
    Sprengeler, PA
    Leahy, EM
    Li, Y
    Shrader, WD
    Burgess-Henry, J
    Sangalang, J
    Verner, EJ
    Allen, D
    Chen, X
    Elrod, KC
    Cregar, L
    Katz, BA
    Luong, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U9 - U9
  • [9] Alternate linkers in a bisamide series of factor Xa inhibitors.
    Goodson, T
    Wiley, MR
    Weir, LC
    Masters, JJ
    Franciskovich, JB
    Tinsley, JM
    Yee, YK
    Tebbe, AL
    Kyle, JB
    Smith, GF
    Craft, TJ
    Towner, RD
    Gifford-Moore, DS
    Herron, DK
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U978 - U979
  • [10] Recombinant Antidote for Reversal of Anticoagulation by Factor Xa Inhibitors.
    Lu, Genmin
    DeGuzman, Francis R.
    Lakhotia, Sanjay
    Hollenbach, Stanley J.
    Phillips, David R.
    Sinha, Uma
    [J]. BLOOD, 2008, 112 (11) : 362 - 362
12345